Profilo
Joseph Frattaroli is the founder of Flagship Consulting, Inc. (founded in 2010).
He was the President, Chief Executive & Financial Officer at Vaso Active Pharmaceuticals, Inc. from 2009 to 2012.
He is currently the Chief Financial Officer at Inhibikase Therapeutics, Inc. (2018-2024).
Mr. Frattaroli obtained his undergraduate degree from Salem State University.
Precedenti posizioni note di Joseph Frattaroli
| Società | Posizione | Fine |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Direttore Finanziario/CFO | 31/03/2024 |
Vaso Active Pharmaceuticals, Inc.
Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Commercializes, markets and sells pharmaceutical products | Direttore Finanziario/CFO | 06/11/2012 |
Flagship Consulting, Inc. | Fondatore | - |
Formazione di Joseph Frattaroli
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Vaso Active Pharmaceuticals, Inc.
Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Commercializes, markets and sells pharmaceutical products | Health Technology |
Salem State University
Salem State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Flagship Consulting, Inc. |
















